Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.

Kundakovic M, Chen Y, Costa E, Grayson DR. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol . 2007 Mar 1 ; 71(3):644-53. PubMed Abstract

Comments on Paper and Primary News
Comment by:  Mary Reid
Submitted 22 November 2006 Posted 24 November 2006

Kundakovic and colleagues find that activation of reelin and GAD67 genes correlated with a reduction in DNA methyltransferase activity and DNMT1 protein levels. Lee and colleagues (2006), report that procainamide is a specific inhibitor of DNMT1. Might we expect that procainamide might restore the reduced reelin and GAD67 protein levels which have been found to be reduced in post-mortem brains of schizophrenic patients?

Is there a reduced risk of schizophrenia for those taking procainamide for rhythm defects and what are the implications for the fact that some atypical antipsychotics as well as procainamide may prolong the QT interval? Has anyone noticed an improvement in clinical stage after commencement of procainamide?

View all comments by Mary Reid

Submit a Comment on this Paper
Make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend this paper

Please note: A member needs to be both registered and logged in to submit a comment.


(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)


SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright